8-K: American Healthcare REIT Completes Public Offering, Lists on NYSE

American Healthcare REIT successfully closed its public offering, raising $717.6 million in net proceeds and listing its common stock on the New York Stock Exchange.

Summary

• American Healthcare REIT completed its underwritten public offering on February 9, 2024, selling 64.4 million shares of common stock, including the full exercise of the underwriters' option.
• The offering generated approximately $717.6 million in net proceeds, which will be used to reduce outstanding debt.
• The company's common stock began trading on the New York Stock Exchange (NYSE) on February 7, 2024, under the ticker symbol AHR.
• Pre-offering stockholders holding Class T and Class I common stock will have their shares automatically converted to NYSE-listed common stock on August 5, 2024.
• The initial public offering price was $12.00 per share.
• The company intends to pay a quarterly distribution of $0.25 per share, or $1.00 annually.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the successful completion of the public offering, the listing on the NYSE, and the company's plans for future growth. The use of terms like 'exciting,' 'important,' and 'attractive' contributes to the positive tone. However, there are some risks and uncertainties mentioned, which prevent a perfect score.

Positives

• The successful public offering provides the company with significant capital to reduce debt and strengthen its balance sheet.
• Listing on the NYSE enhances the company's access to public capital markets and positions it for future growth.
• The offering provides liquidity for pre-offering stockholders when their shares convert to listed common stock.
• The company's diversified portfolio and strong senior housing fundamentals are expected to drive future growth.
• The company has identified multiple avenues for external growth, including potential acquisitions and development opportunities.

Negatives

• Pre-offering stockholders cannot sell their shares on the NYSE until August 5, 2024.
• The company's management and board members are also subject to a 180-day lock-up period.
• The initial public offering price of $12.00 per share was different from the last determined net asset value (NAV) per share, which was last updated as of December 31, 2022.
• The company's share repurchase plan (SRP) and distribution reinvestment plan (DRIP) remain suspended.

Risks

• The company's stock price may fluctuate due to various factors, including market conditions and the performance of healthcare REITs.
• There are uncertainties about whether and when interest rates will continue to increase, which could impact the company's cost of capital.
• The company faces competition in the real estate industry and must successfully identify and integrate new acquisitions.
• Cybersecurity incidents and information technology failures could disrupt operations.
• The company's ability to maintain its qualification as a REIT is subject to legislative and regulatory changes.

Future Outlook

The company aims to strengthen its balance sheet, improve its cost of capital, and enhance performance through internal and strategic external growth. They also plan to explore opportunities for acquisitions and development, including a potential buyout of the remaining minority share of Trilogy.

Management Comments

• The company's executive management team and Board of Directors believe the offering was an important step towards providing access to attractive capital from the public markets.
• Management is enthusiastic and focused on creating value for the company's stockholders through the public markets.
• The management team is committed to maintaining a dialogue with all of our investors through our public filings and future earnings releases.

Industry Context

The healthcare real estate sector is experiencing a growing demand due to an aging population and increasing life expectancy. The company believes this trend will benefit all healthcare real estate asset classes. The company's diversified portfolio and strategic approach to capital allocation position it well to capitalize on these trends.

Comparison to Industry Standards

• The document highlights that AHR's operating portfolio (SHOP & ISHC/Trilogy) has shown substantial year-over-year occupancy, revenue, and NOI growth, outperforming some peers.
• AHR's same-store NOI growth is significantly higher than some diversified healthcare REITs, indicating strong operational performance.
• The document notes that assisted living construction starts are at their lowest level since 2010, while absorption remains historically high, suggesting a favorable supply-demand dynamic for senior housing.
• The company's strategic acquisition of a distressed senior housing portfolio in Texas, followed by the installation of a new operator, resulted in a significant increase in occupancy, demonstrating the company's ability to improve asset performance.
• The document compares AHR's share price performance to other healthcare REITs, showing that while healthcare REIT stock prices are below pre-pandemic highs, they have risen from pandemic lows.

Corporate Governance

Stakeholder Impact

• Shareholders will benefit from the company's improved financial position and potential for future growth.
• Pre-offering stockholders will gain liquidity when their shares convert to NYSE-listed common stock.
• Employees may benefit from the company's growth and success.
• Customers and tenants may benefit from the company's continued investment in its properties and services.
• Creditors will benefit from the company's reduced debt and stronger balance sheet.

Next Steps

• The company will continue to focus on reducing debt and strengthening its balance sheet.
• The company will explore opportunities for internal and external growth, including acquisitions and development.
• The company will continue to communicate with stockholders through public filings and future earnings releases.
• Pre-offering stockholders will have their shares automatically converted to NYSE-listed common stock on August 5, 2024.

Key Dates

Keywords

public offering, NYSE listing, healthcare REIT, common stock, capital raise, debt reduction, senior housing, real estate investment trust, AHR, liquidity